Amplia and ANZGOG Finalise Protocol HIGHLIGHTS The PRROSE trial will investigate the combination of narmafotinib with standard of care chemotherapy in patients with advanced ovarian cancer Following close collaboration between ANZGOG and Amplia the clinical trial protocol [...]
Australia's National Gynaecological Cancer Roundtable Charts United Path Forward on Women's Health Sector leaders, government and women with lived experience unite in Canberra to accelerate evidence-based action, as diagnoses are set to rise 21 per cent over [...]
Volunteering That Changes Lives: ANZGOG Celebrates Community Heroes During National Volunteer Week This National Volunteer Week (19–25 May), the Australia New Zealand Gynaecological Oncology Group (ANZGOG) proudly honours the remarkable contributions of more than 150 community volunteers [...]
The Gynaecological Cancer Transformation Initiative (GCTI) For the first time, women with lived experience, leading gynaecological cancer organisations, and Australia’s top clinical and pre-clinical researchers have united to create a bold, national plan: The Gynaecological Cancer Transformation Initiative [...]
A message to our communities A new initiative aiming to revolutionise the diagnosis, treatment and care pathway for women with gynaecological cancers is soon to be launched to the Australian public, as we work to secure a [...]
ANZGOG welcomes the Federal Budget’s investment in medical research and clinical trials and highlights the need for continued focus on gynaecological cancers The Australia New Zealand Gynaecological Oncology Group (ANZGOG) welcomes key initiatives in the Federal Budget that [...]
Global Leader in Gynaecologic Oncology to Keynote ANZGOG Annual Scientific Meeting The Australia New Zealand Gynaecology Oncology Group (ANZGOG) is delighted to welcome Dr. Lisa Bazzett-Matabele, a distinguished gynaecological oncologist and global health advocate, as an international keynote speaker [...]
Be the Voice That Makes a Difference: Survivors Teaching Students Webinar on 27 February The Australia New Zealand Gynaecological Oncology Group (ANZGOG) is calling on people with a lived experience of ovarian and other gynaecological cancers, including those personally [...]
Ovarian cancer is now confirmed as the deadliest women’s cancer, with the latest statistics revealing a five-year survival rate of just 49%. Tragically, two-thirds (67%) of cases are diagnosed at an advanced stage, where survival drops to just 29%1. [...]
The Australia New Zealand Gynaecological Oncology Group (ANZGOG) is pleased to welcome internationally renowned Radiation Oncologist Professor Carien Creutzberg as a keynote speaker at the 2024 ANZGOG Annual Scientific Meeting (ASM), taking place in Canberra from 5-7 March 2025. [...]
Australia New Zealand Gynaecological Oncology Group www.anzgog.org.au
Level 6, Lifehouse, 119-143 Missenden Road Camperdown NSW 2050 T:+61 2 8071 4880
E: contact@anzgog.org.au © 2026 ANZGOG | Copyright | Disclaimer | ANZGOG Policies | Whistleblower
Virtually every advance in cancer survival has been made on the back of clinical trials.
As the peak, national gynaecological cancer clinical trials organisation for Australia and New Zealand, ANZGOG‘s purpose is to improve outcomes and quality of life for women with gynaecological cancer by conducting research.
We conduct and promote clinical trials and undertake multidisciplinary research into the causes, prevention and treatments of gynaecological cancers.
Research Community Volunteers will have the opportunity to contribute to ANZGOG research at every stage of the development process.
Community volunteers will lend their voices to research discussions sharing their personal perspective and representing the broader views of people with lived experience of gynaecological cancer.
Opportunities range from sharing your lived experience as a participant on a research grant working party or a Trial Management Committee, through to Research Advisor and Expert roles requiring additional levels of education and expertise in research analysis.
Gynaecological cancer research is critically needed but critically underfunded. WomenCan is the fundraising arm of ANZGOG, supporting ANZGOG by funding our programs to improve life for women with gynaecological cancer.
WomenCan’s mission is to engage the community to fund pioneering discoveries that will enable women with a gynaecological cancer to live better and live longer.
WomenCan believes the power of the collective, united in a common purpose, can make a real difference in the lives of women with gynaecological cancers.
ANZGOG’s Survivors Teaching Students (STS) Program is a ground-breaking volunteer program that brings gynaecological cancer survivors and caregivers into the classrooms of health professional students to teach them about women’s experiences with the diseases.
Survivors and caregivers are in a unique position to help students understand the ‘lived experience’ of a gynaecological cancer, including the psychosocial impact, and the importance of timely diagnosis, good health communication and compassionate care.
By joining STS and sharing your story, you will have the opportunity to impact the future care of women diagnosed with a gynaecological cancer, with participating students reporting not only increased understanding of gynaecological cancers but also a deeper understanding of the patient experience to take forward into their practice.
Since the program began at ANZGOG in 2017, our volunteers have shared their stories with more than 11,000 students across Australia and New Zealand.
